COMP <GO>
HY vs GENC // DIVIDEND YIELD & FCF PAYOUT SAFETY
Hyster-Yale Inc. (Class A) (NYSE) VS. Gencor Industries Inc. (NYSE) • 15-METRIC TALLY: HY 3
— GENC 7
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: HY
LAST: $29.34 (0.00%) • MKT CAP: $526.1M
dividend-safety
4.83%
LAST: $17.36 (+1.22%) • MKT CAP: $254.5M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HY VS. GENC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HY | GENC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 16.80% | 27.50% | -10.70 | GENC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.70% | 6.20% | -9.90 | GENC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.49% | 1.21% | +3.28 | HY | /fcf-yield <GO> |
| Operating Margin | -0.60% | 12.10% | -12.70 | GENC | /operating-margins <GO> |
| Net Profit Margin | -1.60% | 13.60% | -15.20 | GENC | /net-margins <GO> |
| Revenue Growth (YoY) | -12.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 4.83% | 0.00% | +4.83 | HY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.44 | 14.16 | -11.72 | GENC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | GENC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.5 | 41.8 | -5.25 | GENC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 15.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $526.1M | $254.5M | $271.6M | HY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HY REV | GENC REV | HY GROSS % | GENC GROSS % | HY FCF | GENC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.77B | $115.4M | 16.8% | 27.5% | $23.6M | $3.1M |
| FY 2024 | $4.31B | $113.2M | 20.8% | 27.7% | $122.9M | $9.3M |
| FY 2023 | $4.12B | $0 | — | — | $150.7M | $10.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HY // BETA —
GENC // BETA —